Circadian Rhythm Disorder — Types, Causes, Diagnosis & Treatment Guide — Symptoms, Causes & Treatment | MyMedicPlus

Circadian rhythm sleep-wake disorders (CRSDs) are a group of conditions in which the timing of the sleep-wake cycle is misaligned with the desired sleep time or with the external light-dark environment. The human circadian clock — located in the suprachiasmatic nucleus (SCN) of the hypothalamus — generates an endogenous approximately 24-hour rhythm that coordinates sleep, wakefulness, body temperature, hormone secretion (melatonin, cortisol), digestion, and many metabolic processes. The SCN is entrained to the 24-hour day primarily by light (the dominant zeitgeber, or time-giver) via retinal photoreceptors (intrinsically photosensitive retinal ganglion cells containing melanopsin — particularly sensitive to short-wavelength blue light). Melatonin (produced by the pineal gland — suppressed by light, peak nocturnal production — is the key signal for sleep onset timing). When the circadian clock is misaligned with social, occupational, or environmental demands, CRSDs result. Major types: delayed sleep-wake phase disorder (DSWPD); advanced sleep-wake phase disorder (ASWPD); non-24-hour sleep-wake rhythm disorder (N24SWD — common in blind individuals); shift work sleep-wake disorder (SWSWD); jet lag disorder; and irregular sleep-wake rhythm disorder (ISWRD — typically in dementia, traumatic brain injury). CRSDs cause not just disrupted sleep but — due to circadian clock misalignment — metabolic, cardiovascular, immune, and psychological dysfunction. Shift workers have significantly increased risk of cardiovascular disease, metabolic syndrome, cancer (breast cancer in women — IARC classifies night shift work as a probable carcinogen Group 2A), and mood disorders.

Circadian rhythm misalignment arises from intrinsic factors (genetic clock variants, neurological conditions), behavioural factors (light exposure, sleep timing), and environmental factors (shift work, travel). Delayed sleep-wake phase disorder (DSWPD — most common CRSD): genetic basis — polymorphisms in circadian clock genes (PER3, CLOCK, CRY1 — particularly CRY1 Thr424Ala mutation that lengthens the circadian period; heritability approximately 50%); characteristically long endogenous circadian period (tau above 24.5 hours — slow clock); evening light exposure — blue-light-emitting screens (smartphones, tablets — melatonin suppression delays the clock); delayed sleep onset in adolescence is physiological (puberty lengthens the circadian period — explains 'night owl' tendencies in teenagers); lifestyle reinforcement of late sleep patterns. Advanced sleep-wake phase disorder (ASWPD): earlier circadian phase — causes difficulty staying awake in the evening and early morning awakening; familial form associated with PER2 phosphorylation mutations; more common in elderly. Non-24-hour sleep-wake rhythm disorder (N24SWD): absence of light entrainment — most commonly in blind individuals (no photic input to SCN); rare in sighted individuals (CRY1 mutation causing very long tau); sleep and wake times drift later by 30-60 minutes daily. Shift work sleep-wake disorder: imposed schedule demands sleep during the circadian day (biological night from the clock's perspective); chronic circadian misalignment; only 25-30% of shift workers develop clinically significant disorder (individual vulnerability factors). Jet lag disorder: rapid transmeridian travel crossing multiple time zones faster than the SCN can re-entrain; eastward travel (advance — harder to adjust) vs westward travel (delay — generally easier); rate of re-entrainment approximately 1 time zone per day eastward, 1.5 zones westward. Non-24 and irregular SWRD: often seen in dementia, traumatic brain injury, and developmental disorders (autism spectrum disorder — delayed and irregular sleep-wake patterns are common).

DSWPD: inability to fall asleep at a desired conventional bedtime (typically not sleeping until 2-6 am); inability to wake at a conventional time (sleeping until 10 am - 12 pm) without alarm; if forced to wake early (school, work), extreme difficulty, profound sleepiness, and impaired performance during morning hours; but if allowed to sleep at the preferred biological time, sleep quality, duration, and morning alertness are normal — there is no intrinsic insomnia. Profound social and occupational dysfunction from incompatibility with conventional schedules — frequently misdiagnosed as 'laziness' or insomnia. Associated with depression, anxiety, and ADHD in adolescents and young adults (shared neurobiological pathways). ASWPD: irresistible sleepiness in the early evening (7-9 pm) with involuntary sleep, and early morning awakening (3-5 am) unable to return to sleep; social/evening activity severely impaired. Shift work disorder: insomnia during the required daytime sleep; excessive sleepiness during night shifts — 2-7 times increased accident risk during night shift work (Chernobyl, Three Mile Island, Bhopal — all occurred during night shifts); impaired cognitive performance, mood, and function; gastrointestinal complaints (circadian misalignment of digestive rhythms); metabolic consequences (obesity, metabolic syndrome). Jet lag: daytime sleepiness, insomnia at the destination's night, impaired concentration and mood, GI upset, malaise — severity proportional to number of time zones crossed; 1-2 days per time zone for full adaptation.

CRSDs are diagnosed primarily by clinical history — detailed sleep-wake history is the cornerstone — supplemented by objective measures. Clinical assessment: ICSD-3 diagnostic criteria for each specific CRSD; detailed sleep-wake history (bedtime, sleep onset, wake time, quality — at least 2 weeks); differentiate from behavioural insomnia (learned arousal at bedtime), depression (hypersomnia with early morning awakening), and other sleep disorders. Actigraphy: wrist-worn accelerometer recording rest-activity cycles continuously for 1-2 weeks — provides objective measure of sleep-wake timing, total sleep time, and daily variability; gold standard for CRSD diagnosis alongside sleep diary. Sleep diary (2-week minimum): patient-recorded bedtime, estimated sleep onset, awakening time, naps, and sleepiness ratings — provides subjective correlate of actigraphy. Dim-light melatonin onset (DLMO): saliva or plasma melatonin sampling every 30-60 minutes in dim light (below 10 lux) from early evening to sleep time — determines the endogenous circadian phase (DLMO occurs approximately 2 hours before habitual sleep onset); delayed DLMO confirms DSWPD; advanced DLMO confirms ASWPD; DLMO is the gold standard for circadian phase assessment but requires specialised protocols. Polysomnography (PSG): typically not required for CRSD diagnosis but performed if comorbid sleep disorders suspected (OSA, periodic limb movement disorder). Genetic testing: CRY1, PER3, CLOCK mutations — available at specialist centres for familial DSWPD. Morningness-Eveningness Questionnaire (MEQ) and Chronotype Assessment questionnaires quantify self-reported chronotype.

CRSD treatment aims to shift (advance or delay) and stabilise the circadian clock to align with desired or required sleep timing. Light therapy: the most powerful zeitgeber for entraining the circadian clock. Morning bright light exposure (10,000 lux, 30-60 minutes, within 30 minutes of desired wake time) advances the circadian clock — used for DSWPD (advance the delayed clock), shift workers transitioning to day shifts, and jet lag from westward travel. Evening bright light delays the clock — used for ASWPD. Commercial bright light therapy boxes (10,000 lux fluorescent or LED — positioned 30-40cm from eyes; avoid direct gaze). Avoid bright light in the evening/night for DSWPD (blue-light blocking glasses). Melatonin: acts as a phase-shifting agent when timed appropriately (not primarily as a sedative). For DSWPD: low-dose melatonin (0.5-1mg — lower doses more physiological than the commonly used 5mg) taken 5-6 hours before the current sleep onset time (e.g., if sleeping at 3am, take at 9pm) — this advances the clock by 1-2 hours per day; combined with morning light therapy provides the most effective treatment. For jet lag eastward: melatonin 0.5-5mg taken at bedtime at the destination for 2-3 days — accelerates re-entrainment. For N24SWD: tasimelteon (Hetlioz — melatonin receptor agonist) is FDA-approved specifically for N24SWD in blind individuals; nightly administration entrains the non-24-hour rhythm to a 24-hour cycle. Chronotherapy: progressive 2-3 hour delay of sleep time each day (for DSWPD) until the desired bedtime is reached; extremely demanding (requires 3-4 weeks out of normal schedule); maintenance requires strict adherence to new schedule; rarely used in practice but effective when adhered to. Sleep hygiene optimisation: consistent sleep-wake times including weekends (social jetlag — sleeping in on weekends perpetuates circadian misalignment); avoid blue light screens 1-2 hours before target bedtime; avoid caffeine after noon; exercise (promotes circadian entrainment — but vigorous exercise close to target sleep time can delay clock). Shift work management: strategic light exposure to anchor the circadian clock to night work (bright light during first half of night shift; dark glasses or blue-light blocking on commute home); strategic napping (20-30 minutes before night shift starts); melatonin before daytime sleep (5mg at the end of the night shift, before sleep); caffeine strategically during night shift (not within 6 hours of planned sleep); fixed schedule (consistent night shift days — rotating shifts are worse than permanent night shifts for circadian adaptation). Modafinil or armodafinil (FDA approved for shift work disorder and narcolepsy — promotes wakefulness without addressing circadian misalignment itself).

Untreated circadian rhythm disorders cause progressive physical, psychological, and social harm. Long-term shift work is associated with significantly elevated rates of cardiovascular disease (23–40% higher risk of coronary artery disease), metabolic syndrome, type 2 diabetes, gastrointestinal disorders, and breast cancer (classified Group 2A probable carcinogen by IARC due to circadian disruption). Untreated delayed sleep-wake phase disorder in adolescents leads to school failure, social isolation, depression, and substance use — outcomes that improve dramatically with appropriate chronotherapy and light therapy. Night shift workers experience 2–7x higher rates of occupational accidents and medical errors from impaired cognitive alertness during circadian nadir. Social isolation from circadian misalignment — inability to participate in social activities during evening hours — causes relationship breakdown and reduced quality of life. Non-24-hour sleep-wake rhythm disorder (especially in blind individuals) causes complete social dysfunction and severe sleep deprivation when untreated. Chronic circadian disruption causes cumulative neurological effects including impaired memory consolidation and increased risk of depression.

Strong circadian entrainment prevents CRSDs and optimises health across multiple physiological systems. Social jetlag prevention: maintain consistent sleep and wake times across all 7 days (weekend sleep variation above 1 hour creates weekly 'jet lag' — particularly harmful for metabolic and cardiovascular health). Light exposure strategy: maximise morning natural light exposure (30+ minutes outdoors in the morning helps anchor the circadian clock); minimise bright light and blue-light screen exposure in the 1-2 hours before target bedtime (use blue-light blocking apps — Night Shift on Apple, Nightmode on Android — or wear blue-light filtering glasses). Temperature: the bedroom should be cool (16-19°C); cooling of core body temperature is part of the circadian sleep-onset signal. Exercise: regular aerobic exercise in the morning or early afternoon has the greatest positive circadian benefit. Meal timing: eating aligned with circadian timing (larger meals earlier in the day, lighter meals in the evening) optimises metabolic outcomes. For shift workers: advocate for fixed schedule (not rotating) night shifts; the Circadian Sleep-Wake Disorders Society and AAASM provide guidelines on shift scheduling to minimise misalignment. Melatonin supplementation in the short term for jet lag prevention and shift work adaptation is safe and effective.

See your GP or request a sleep medicine referral for: persistent inability to fall asleep at a conventional bedtime despite adequate opportunity (and normal sleep if allowed to sleep at preferred later time) — possible DSWPD; morning awakening consistently 3-5 hours earlier than desired with inability to return to sleep (possible ASWPD); sleep timing that drifts progressively later every day regardless of attempts to keep consistent timing (possible N24SWD); and shift work-related sleep and wakefulness problems that are significantly impairing work performance, safety, or wellbeing. Referral to a sleep medicine specialist or chronobiology clinic for: confirmed or suspected circadian rhythm disorder where first-line light therapy and melatonin have not resolved the issue; adolescents with DSWPD causing significant school attendance difficulties or academic failure (DSWPD is frequently misdiagnosed in this population as 'laziness' or school refusal); adults whose occupational functioning is severely affected (e.g., healthcare workers, transport workers, security personnel — safety-critical roles); and suspected N24SWD in blind or visually impaired individuals. Actigraphy monitoring for 2 weeks (wrist-worn device available on prescription) helps confirm circadian disorder diagnosis and guides treatment timing.